Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scopolamine + chlorpromazine for prevention of heroin relapse
ChiCTR-TRC-09000490Phase 4Recruiting
- Sponsor
- Ningbo Addiction Research and Treatment Center
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of scopolamine, Aminazin and methadone in heroin addiction and opioid use disorder (OUD) (2 arms), sponsored by Ningbo Addiction Research and Treatment Center. Primary endpoint: Psychometrical scale for protracted withdrawal symptoms of opiate dependence. Started Jul 2009; status: recruiting.
02
Drugs
scopolamineAminazinmethadone
03
Conditions
heroin addictionopioid use disorder (OUD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000490.